JW (Cayman) Therapeutics Co. Ltd.(HK:2126)
HK$2.70+0.13 (+5.06%)
HK:2126
JW (Cayman) Therapeutics Co. Ltd. financials statements
HK$2.70
At close:+0.13 (+5.06%)
Want to see HK:2126 full AI Analyst Report?
JW (Cayman) Therapeutics Co. Ltd. (2126) Income Statement
0 Followers
JW (Cayman) Therapeutics Co. Ltd. Income Statement
Last quarter (Q2 2026), JW (Cayman) Therapeutics Co. Ltd.'s total revenue was ¥111.48M, an increase of 28.41% from the same quarter last year. In Q2, JW (Cayman) Therapeutics Co. Ltd.'s net income was ¥-50.48M. See JW (Cayman) Therapeutics Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 276.31M | ¥ 158.22M | ¥ 173.86M | ¥ 145.70M | ¥ 30.80M | |
| ¥ 118.91M | ¥ 77.32M | ¥ 88.22M | ¥ 58.76M | ¥ 9.04M | |
| ¥ 360.62M | ¥ 536.60M | ¥ 877.83M | ¥ 914.64M | ¥ 768.13M | |
| Depreciation and Amortization | ¥ 81.88M | ¥ 89.66M | ¥ 99.83M | ¥ 87.07M | ¥ 48.23M |
| ¥ -159.83M | ¥ -369.37M | ¥ -655.75M | ¥ -752.27M | ¥ -723.49M | |
| ¥ -241.71M | ¥ -459.28M | ¥ -789.61M | ¥ -855.88M | ¥ -759.08M | |
| ¥ -296.22M | ¥ -131.34M | ¥ 21.61M | ¥ 9.75M | ¥ 56.76M | |
| ¥ -537.93M | ¥ -590.62M | ¥ -768.00M | ¥ -846.13M | ¥ -702.33M | |
| ¥ -540.92M | ¥ -590.62M | ¥ -768.00M | ¥ -846.13M | ¥ -702.33M | |
| Per Share Metrics | |||||
| Basic EPS | ¥ -1.30 | ¥ -1.43 | ¥ -1.87 | ¥ -2.06 | ¥ -1.76 |
| Diluted EPS | ¥ -1.30 | ¥ -1.43 | ¥ -1.87 | ¥ -2.06 | ¥ -1.76 |
| Weighted Average Shares Outstanding | 415.79M | 413.63M | 411.53M | 410.09M | 399.75M |
| Weighted Average Shares Outstanding (Diluted) | 415.79M | 413.63M | 411.53M | 410.09M | 399.75M |
Currency in CNY
